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SUMMARY 
Conventional neurochemical animal models of tardive dyskinesia are based upon the production of 
dopamine postsynaptic receptor supersensitivity by the chronic administration of neuroleptics. This study 
demonstrates that the same result is obtained by injecting Sprague-Dawley rats with a single ('high') dose of 
ipomorphine. It is hence suggested that apomorphine-induced time-dependant potentiation of dopamine-
postsynaptic receptor response may be a more convenient neurochemical animal model cf tardive dyskinesia; 
related theoretical and practical issues are discussed briefly, as also the methodological differences between 
the present study and an earlier report. 
Animal models of human illness 
states are necessary to conveniently investi-
gate pathophysiological processes. Avail-
able models for tardive dyskinesia (TD) 
are based upon the production of dopa-
mine (DA) postsynaptic receptor super-
sensitivity (the putative neurochemical 
basis of TD) by the chronic administra-
tion of neuroleptic drugs. This model 
is essentially neurochemical as in rodents, 
unlike as in primates, no movement disor-
der is apparent (Goetz et al., 1983). It 
may hence be argued that whatever the 
means by which such a change is elicited, 
the production of supersensitive DA post-
synaptic receptors could constitute a 
neurochemical animal model of TD. 
The present study expands upon an ear-
lier report (Andrade et al., 1990) that 
a single 'high' dose apomorphinc chal-
lenge produces time-dependant potentia-
tion of DA postsynaptic receptor response, 
suggesting that restricted apomorphine 
challenge could replace the need for chro-
nic neuroleptic administration in rodent 
models of TD. 
Methodology 
Eighteen adult, male, Sprague-Daw-
ley rats (160-200 gm in body weight) 
obtained from the Central Animal Resea-
rch Facility at the National Institute of 
Mental Health and Neurosciences (Ban-
galore) were housed two per cage with 
free access to tap water and standard 
laboratory diet. The animals were 
brought into a temperature and humidity 
controlled, 12 hour light-dark cycle 
(lights on at 6 a.m.), sound proof, insula-
ted room one week before commencement 
of the experiment, and were maintained 
in this environment until the end of the 
study. 
Dopamine postsynaptic receptor fun-
ction was studied using the apomorphine-
induced behaviour alteration paradigm: 
in high doses (e. g. exceeding 1 mg/kg 
body weight) apomprphine, a direct DA 
agonist, stimulates the DA postsynaptic 
receptors leading to stereotypic behaviour 
and hypei motility; quuiuifir.uion of this 
behaviour change yields an index of recep-
tor function (Nilsson and Carlsson, 1982; 
Arunasmitha et al., 1989). In the present 
study, apomorphine was used in the dose 
of 2mg/kg body weight, and the behaviour 
selected for quantification was animal 
motility. 
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In each cage, one animal (experi-
mental) was subcutaneously (nape of the 
neck) injected with freshly-dissolved apo-
morphine (SIGMA chemicals, USA) in 
a vehicle (normal saline) of volume 1 mg/ 
kg body weight, while the other animal 
(control) was injected with vehicle alone. 
Twenty minutes after the injection, 
the motility of each animal was assessed 
according to the procedure described for 
the small open field (Van Ree and de 
Wied, 1988): the animal was placed in 
a glass cylinder measuring 45 cm in height 
and 22 cm in internal diameter, and the 
number of quadrants (marked on the 
floor of the cylinder) crossed by the ani-
mal during a 3 minute monitoring period 
was noted by a trained observer blind to 
the experimental status of the rats. 
Motility monitoring was conducted bet-
ween 9a.m. and 11 a.m. to control for 
diurnal variation in motility. 
One week later, the injections and 
monitoring were repeated in an identical 
fashion. The change in motility scores 
across time in the experimental group 
describes the change in DA postsynaptic 
receptor function as elicited by the initial 
apomorphine challenge in this group, 
while the behaviour of the saline-injected 
group serves to control for handling and 
environment related effects. 
Results 
The baseline and one week post-
baseline motility scores in the experimen-
tal and control groups are presented in 
the Table. A two group two way repeat 
measures ANOVA revealed a significant 
main effect for groups (F=27.53, d. f.= 
1, 16, p<0.001) which indicates that the 
experimental group was significantly more 
motile than tlie control group (which 
result is expectable, as apomorphine 
enhances motility via DA postsynaptic 
receptor mechanisms), a non-significant 
main effect for the time (F=»4.32, d. f.= 
TABLE—Mean±SEM quadrants crossed by 
expert mental and control rats at base-
line and one week post-baseline 
Baseline One week 
post-baseline 
Experimental 51.44 71.78 
(n=9) ±9.86 ±11.19 
Control 11.67 9.0 
(n=9) ± 0.75 ± 2.01 
1,16, N. S.) which indicates that, consi-
dered together, the two groups did not 
change significantly across time, and a 
significant group X time interaction 
effect (F=7.32, d. f. = l,16, p<0.025) 
which indicates that there was significant 
increase in motility in the experimental 
group across time, as distinct from the 
change in scores in the control group. 
Discussion 
As apomorphine-elicited motility 
significantly increased (across time) in the 
experimental group relative to the con-
trol group, one must conclude that die 
DA postsynaptic receptors (responsible 
for the motility in the experimental group) 
had become supersensitive to apomor-
phine i.e., fulfilling the requirements for 
the neurochemical basis of TD. 
It is well-known that, in general, 
the chronic administration of DA agonists 
(e.g. L-dopa) diminishes while the chro-
nic administration of DA antagonists 
(e.g. haloperidol) increases agonist-elici-
ted (e.g. using apomorphine) DA postsy-
naptic receptor responses; however, it 
has recently been recognized that the 
spaced (as opposed to the masses or chro-
nic) administration of a DA agonist can 
paradoxically sensitiae these postsynap-
tic receptors (Rebec, 1984; Castro et al., 
1985). The present study demonstrates 
that even a single 'high' dose of apomor-
phine can sensitiae DA postsynaptic re-T.D.: A POTENTIAL NEW NEUROOHBMICAL ANIMAL MODEL 275 
ceptors at a period extending upto at 
least 1 week after the challenge. 
An earlier study (Andrade et al., 
1990) had described apomorphine-indu-
ced time-dependant potentiation of DA 
postsynaptic receptor response using an 
experimental design wherein receptor 
function was studied cross-sectionally in 
animals pre-treated with apomorphine or 
saline; the present study describes the 
same results using an experimental designs 
wherein receptor function was studied 
longitudinally in animals treated with 
apomorphine or saline. In other words, 
the former study described DA postsynap-
tic receptor supersensitivity relative to a 
control group at a single point in time, 
while the present study describes DA 
postsynaptic receptor supersensitivity 
actually developing across time. The 
two studies may thus be considered to 
complement each other. 
There is no reason to suppose that 
DA postsynaptic receptor supersensitivity 
produced by one means is any different 
from that produced by another means; 
hence, however elicited, these receptor 
changes, when occuring, could equally 
be considered as models of TD. Chronic 
neuroleptic administration requires 3 
weeks for the production of the necessary 
receptor changes in rats (Goetz ct al., 
1983); this is far more troublesome and 
time-consuming than the present method 
wherein a single injection of apomorphine 
suffices, to elicit the desired effects. Fur-
ther research is warranted to describe the 
relative extent (in various DA systems in 
the brain), magnitude and duration of 
receptor change as produced by the two 
methods. 
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